These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7890044)

  • 1. Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption.
    Nakamura I; Takahashi N; Sasaki T; Tanaka S; Udagawa N; Murakami H; Kimura K; Kabuyama Y; Kurokawa T; Suda T
    FEBS Lett; 1995 Mar; 361(1):79-84. PubMed ID: 7890044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders.
    Murakami H; Takahashi N; Sasaki T; Udagawa N; Tanaka S; Nakamura I; Zhang D; Barbier A; Suda T
    Bone; 1995 Aug; 17(2):137-44. PubMed ID: 8554921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts.
    Nakamura I; Sasaki T; Tanaka S; Takahashi N; Jimi E; Kurokawa T; Kita Y; Ihara S; Suda T; Fukui Y
    J Cell Physiol; 1997 Aug; 172(2):230-9. PubMed ID: 9258344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, inhibits osteoclastic bone resorption in vitro.
    Hall TJ; Jeker H; Schaueblin M
    Calcif Tissue Int; 1995 Apr; 56(4):336-8. PubMed ID: 7767847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of wortmannin analogs on bone in vitro and in vivo.
    Sato M; Bryant HU; Dodge JA; Davis H; Matter WF; Vlahos CJ
    J Pharmacol Exp Ther; 1996 Apr; 277(1):543-50. PubMed ID: 8613966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts.
    Murakami H; Takahashi N; Tanaka S; Nakamura I; Udagawa N; Nakajo S; Nakaya K; Abe M; Yuda Y; Konno F; Barbier A; Suda T
    Bone; 1997 May; 20(5):399-404. PubMed ID: 9145236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destruxins, cyclodepsipeptides, block the formation of actin rings and prominent clear zones and ruffled borders in osteoclasts.
    Nakagawa H; Takami M; Udagawa N; Sawae Y; Suda K; Sasaki T; Takahashi N; Wachi M; Nagai K; Woo JT
    Bone; 2003 Sep; 33(3):443-55. PubMed ID: 13678787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts.
    Woo JT; Kasai S; Stern PH; Nagai K
    J Bone Miner Res; 2000 Apr; 15(4):650-62. PubMed ID: 10780857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
    Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts.
    Suzuki H; Nakamura I; Takahashi N; Ikuhara T; Matsuzaki K; Isogai Y; Hori M; Suda T
    Endocrinology; 1996 Nov; 137(11):4685-90. PubMed ID: 8895334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multinucleated cells formed on calcified dentine from mouse bone marrow cells treated with 1 alpha,25-dihydroxyvitamin D3 have ruffled borders and resorb dentine.
    Sasaki T; Takahashi N; Higashi S; Suda T
    Anat Rec; 1989 Jul; 224(3):379-91. PubMed ID: 2782622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact.
    Jimi E; Nakamura I; Amano H; Taguchi Y; Tsurukai T; Tamura M; Takahashi N; Suda T
    Endocrinology; 1996 May; 137(5):2187-90. PubMed ID: 8612568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wortmannin blocks lipid and protein kinase activities associated with PI 3-kinase and inhibits a subset of responses induced by Fc epsilon R1 cross-linking.
    Barker SA; Caldwell KK; Hall A; Martinez AM; Pfeiffer JR; Oliver JM; Wilson BS
    Mol Biol Cell; 1995 Sep; 6(9):1145-58. PubMed ID: 8534912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts.
    Nakamura I; Takahashi N; Sasaki T; Jimi E; Kurokawa T; Suda T
    J Bone Miner Res; 1996 Dec; 11(12):1873-9. PubMed ID: 8970888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of kampo formulae on bone resorption in vitro and in vivo. II. Detailed study of berberine.
    Li H; Miyahara T; Tezuka Y; Namba T; Suzuki T; Dowaki R; Watanabe M; Nemoto N; Tonami S; Seto H; Kadota S
    Biol Pharm Bull; 1999 Apr; 22(4):391-6. PubMed ID: 10328560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact.
    Jimi E; Nakamura I; Amano H; Taguchi Y; Tsurukai T; Tamura M; Takahashi N; Suda T
    Endocrinology; 1996 Aug; 137(8):2187-90. PubMed ID: 8754795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of focal adhesion kinase, p125FAK, in osteoclastic bone resorption.
    Tanaka S; Takahashi N; Udagawa N; Murakami H; Nakamura I; Kurokawa T; Suda T
    J Cell Biochem; 1995 Aug; 58(4):424-35. PubMed ID: 7593264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
    Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
    J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of isoform-selective phosphatidylinositol 3-kinase inhibitors on osteoclasts: actions on cytoskeletal organization, survival, and resorption.
    Shugg RP; Thomson A; Tanabe N; Kashishian A; Steiner BH; Puri KD; Pereverzev A; Lannutti BJ; Jirik FR; Dixon SJ; Sims SM
    J Biol Chem; 2013 Dec; 288(49):35346-57. PubMed ID: 24133210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
    Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
    Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.